$1.00 -0.02 (-1.95%)
11/25/2009 10:38 AM

Aeterna Zentaris, Inc. (USA) (AEZS)

CAPS Rating: 5 out of 5

A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.

Featured Broker Partners